Naren L Banik Selected Research

Apigenin

10/2013	N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification.
9/2013	Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells.
6/2013	miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.
6/2013	KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells.
9/2011	Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells.
1/2010	Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes.
10/2009	Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.
12/2006	Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naren L Banik Research Topics

Disease

41	Glioblastoma (Glioblastoma Multiforme) 06/2016 - 07/2002
34	Neoplasms (Cancer) 01/2016 - 07/2002
30	Spinal Cord Injuries (Spinal Cord Injury) 02/2022 - 05/2003
23	Neuroblastoma 07/2014 - 12/2006
20	Inflammation (Inflammations) 01/2022 - 05/2008
10	Gliosis 11/2021 - 06/2010
10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 04/2003
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 05/2004
8	Parkinson Disease (Parkinson's Disease) 01/2022 - 06/2008
8	Multiple Sclerosis 01/2018 - 04/2003
8	Wounds and Injuries (Trauma) 03/2010 - 05/2003
5	Demyelinating Diseases (Demyelinating Disease) 10/2017 - 06/2008
5	Brain Neoplasms (Brain Tumor) 08/2013 - 07/2002
4	Optic Neuritis (Retrobulbar Neuritis) 10/2016 - 08/2005
4	Parkinsonian Disorders (Parkinsonism) 10/2008 - 08/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 06/2002
3	Disease Progression 01/2020 - 10/2015
3	Neuroinflammatory Diseases 02/2018 - 04/2003
3	Meningioma (Meningiomas) 09/2015 - 07/2002
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2013 - 08/2005
3	Edema (Dropsy) 05/2008 - 12/2004
2	Vision Disorders (Hemeralopia) 10/2016 - 07/2011
2	Necrosis 06/2016 - 12/2007
2	Muscular Atrophy (Muscle Atrophy) 02/2016 - 11/2012
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 01/2016
2	Nervous System Diseases (Neurological Disorders) 01/2016 - 06/2008
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 06/2008

Drug/Important Bio-Agent (IBA)

40	CalpainIBA 01/2022 - 06/2002
17	Estrogens (Estrogen)FDA Link 11/2021 - 11/2004
12	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2003
11	calpain inhibitorsIBA 01/2022 - 05/2003
10	CaspasesIBA 06/2016 - 05/2003
10	Caspase 3 (Caspase-3)IBA 03/2016 - 07/2002
10	GenisteinIBA 01/2013 - 12/2006
10	Paclitaxel (Taxol)FDA LinkGeneric 12/2012 - 11/2007
10	FenretinideIBA 05/2012 - 03/2008
9	CytokinesIBA 10/2020 - 08/2011
9	Small Interfering RNA (siRNA)IBA 10/2013 - 01/2009
9	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2013 - 12/2007
9	retinamideIBA 05/2012 - 08/2008
9	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 05/2007
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2002
8	ApigeninIBA 10/2013 - 12/2006
8	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2010 - 05/2007
7	Phosphopyruvate Hydratase (Enolase)IBA 09/2021 - 01/2016
7	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020 - 06/2002
7	calpeptinIBA 12/2018 - 08/2005
7	Neuroprotective AgentsIBA 01/2016 - 11/2004
7	Cysteine Proteases (Cysteine Protease)IBA 04/2011 - 05/2003
6	RetinoidsIBA 11/2011 - 03/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 12/2007
5	SurvivinIBA 08/2013 - 12/2007
5	MelatoninIBA 01/2013 - 05/2008
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 09/2007
4	ChemokinesIBA 10/2020 - 01/2016
4	Myelin Basic ProteinIBA 01/2018 - 10/2003
4	AntigensIBA 10/2016 - 01/2011
4	Phosphotransferases (Kinase)IBA 06/2016 - 09/2007
4	Caspase 8 (Caspase-8)IBA 06/2016 - 12/2006
4	Temozolomide (Temodar)FDA LinkGeneric 01/2015 - 12/2004
4	RotenoneIBA 07/2014 - 08/2006
4	FlavonoidsIBA 08/2012 - 12/2006
4	Pharmaceutical PreparationsIBA 06/2012 - 04/2003
3	SynucleinsIBA 01/2022 - 01/2019
3	Sepharose (Agarose)IBA 01/2021 - 07/2002
3	EnzymesIBA 10/2020 - 11/2012
3	Peptides (Polypeptides)IBA 01/2018 - 05/2007
3	Biological ProductsIBA 10/2017 - 08/2008
3	Transcription Factors (Transcription Factor)IBA 06/2013 - 04/2011
3	TeaIBA 02/2013 - 08/2011
3	MicroRNAs (MicroRNA)IBA 02/2013 - 05/2012
3	gallocatechol (epigallocatechin)IBA 02/2013 - 12/2006
3	CurcuminIBA 12/2012 - 10/2006
3	SteroidsIBA 06/2010 - 12/2004
3	p38 Mitogen-Activated Protein KinasesIBA 01/2010 - 09/2007
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2008 - 12/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 05/2008 - 12/2004
3	Caspase 9IBA 03/2008 - 07/2002
2	AntioxidantsIBA 11/2021 - 08/2011
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2021 - 11/2007
2	ENOblockIBA 10/2020 - 10/2017
2	Neurofilament ProteinsIBA 10/2016 - 01/2013
2	Cathepsin BIBA 06/2016 - 06/2008
2	salicylhydroxamic acid (SHAM)IBA 03/2016 - 02/2016
2	UbiquitinIBA 02/2016 - 11/2012
2	Ligases (Synthetase)IBA 02/2016 - 11/2012
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2011
2	Therapeutic UsesIBA 02/2015 - 10/2006
2	RNA (Ribonucleic Acid)IBA 01/2014 - 07/2002
2	calpastatinIBA 12/2013 - 11/2012
2	diallyl trisulfideIBA 08/2013 - 09/2007

Therapy/Procedure

27	Therapeutics 01/2022 - 04/2005
7	Drug Therapy (Chemotherapy) 01/2015 - 07/2002
7	Aftercare (After-Treatment) 11/2010 - 12/2007
4	Radiotherapy 06/2016 - 07/2002
3	Immunotherapy 04/2014 - 12/2007
2	Laminectomy 03/2016 - 02/2016
2	Lasers (Laser) 01/2016 - 08/2012
2	Immunomodulation 07/2014 - 08/2013
2	Intraperitoneal Injections 08/2013 - 07/2011